To be more specific, hesperidin modulates AMPK and PPAR signaling pathways in obesity treatment, which affects the antioxidant index, anti-apoptosis, and NF-κB signaling pathways indirectly [30]. The gene discussed is NFKB1; the disease is obesity due to melanocortin 4 receptor deficiency.